HCA Healthcare, Inc.

Tickers
HCA
Headquarters
Not recorded
SEC CIK
0000860730
Website
Not recorded

Closing prices

Latest close, 478.08

Closing prices for HCA249 stored closes for HCA from 3 Nov 2025 to 29 Oct 2026. Lowest 361.32 on 8 Jun 2026, highest 545.13 on 9 Mar 2026, latest 478.08 on 29 Oct 2026.Close350.00400.00450.00500.00550.003 Nov 20251 May 202629 Oct 2026
249 stored closes, oldest first. End of day, not intraday.

Drugs

No drugs from this company are tracked yet.

FDA-approved applications

No Drugs@FDA application has a sponsor name that matches this company.

Data provided by the U.S. Food and Drug Administration (Drugs@FDA). Sponsors are matched to companies by name; subsidiaries do not link.

Catalysts

No catalysts yet. Editors add each date together with its source.

Deals

No approved deals involve this company yet.

Reported fundamentals (SEC XBRL)

Latest value of each metric as reported to the SEC
MetricReported valuePeriodFiling
Revenue19,849,000,000 USD 1 Jul 2026 to 30 Sep 2026 FY2026 Q310-Q for Revenue on sec.gov (opens in a new tab)Filed
Net income (loss)1,579,000,000 USD 1 Jul 2026 to 30 Sep 2026 FY2026 Q310-Q for Net income (loss) on sec.gov (opens in a new tab)Filed
Research and development expenseNot reported in XBRL filings since 2015
Operating expenses17,479,000,000 USD 1 Jul 2026 to 30 Sep 2026 FY2026 Q310-Q for Operating expenses on sec.gov (opens in a new tab)Filed
Cash and cash equivalents908,000,000 USD At 30 Sep 2026 FY2026 Q310-Q for Cash and cash equivalents on sec.gov (opens in a new tab)Filed
Short-term investments and marketable securities121,000,000 USD At 30 Sep 2022 FY2022 Q310-Q for Short-term investments and marketable securities on sec.gov (opens in a new tab)Filed
Total liabilities45,623,000,000 USD At 31 Dec 2019 FY201910-K for Total liabilities on sec.gov (opens in a new tab)Filed
Stockholders' equity−8,077,000,000 USD At 30 Sep 2026 FY2026 Q310-Q for Stockholders' equity on sec.gov (opens in a new tab)Filed
Common shares outstanding (cover page)208,892,500 shares At 26 Oct 2026 FY2026 Q310-Q for Common shares outstanding (cover page) on sec.gov (opens in a new tab)Filed

History

Revenue, newest period first
PeriodReported valueFiling
1 Jul 2026 to 30 Sep 2026 FY2026 Q319,849,000,000 USD10-Q filed 29 Oct 2026 on sec.gov (opens in a new tab)Filed
1 Apr 2026 to 30 Jun 2026 FY2026 Q220,230,000,000 USD10-Q filed 28 Jul 2026 on sec.gov (opens in a new tab)Filed
1 Jan 2026 to 31 Mar 2026 FY2026 Q119,109,000,000 USD10-Q filed 29 Apr 2026 on sec.gov (opens in a new tab)Filed
1 Jan 2025 to 31 Dec 2025 FY202575,600,000,000 USD10-K filed 10 Feb 2026 on sec.gov (opens in a new tab)Filed
1 Jul 2025 to 30 Sep 2025 FY2026 Q319,161,000,000 USD10-Q filed 29 Oct 2026 on sec.gov (opens in a new tab)Filed
1 Apr 2025 to 30 Jun 2025 FY2026 Q218,605,000,000 USD10-Q filed 28 Jul 2026 on sec.gov (opens in a new tab)Filed
1 Jan 2025 to 31 Mar 2025 FY2026 Q118,321,000,000 USD10-Q filed 29 Apr 2026 on sec.gov (opens in a new tab)Filed
1 Jan 2024 to 31 Dec 2024 FY202570,603,000,000 USD10-K filed 10 Feb 2026 on sec.gov (opens in a new tab)Filed

The newest 12 periods of each metric are listed; older ones are on sec.gov.

Values as reported in the company's XBRL filings to the SEC, one per calendar period (SEC frames); not adjusted, not audited by HealthTrade, and not investment advice.

Source: SEC XBRL company facts (opens in a new tab) · Licence: public-domain · as of 2026-10-30 · read

SEC filings

SEC filings from HCA Healthcare, Inc., newest first
FormFiledWhat it coversDocument
10-Q Quarterly report (10-Q) View Quarterly report (10-Q) filed 29 Oct 2026 on sec.gov (opens in a new tab)Filing index for 0001193125-26-437871 (opens in a new tab)
8-K Current report (8-K) View Current report (8-K) filed 27 Oct 2026 on sec.gov (opens in a new tab)Filing index for 0001193125-26-432665 (opens in a new tab)
4Event 26 Aug 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 28 Aug 2026 on sec.gov (opens in a new tab)Filing index for 0001193125-26-374693 (opens in a new tab)
8-K Current report (8-K)
  • Creation of a direct financial obligation (Item 2.03)
  • Other events (Item 8.01)
View Current report (8-K) filed 29 Jul 2026 on sec.gov (opens in a new tab)Filing index for 0001193125-26-323731 (opens in a new tab)
10-QEvent 30 Jun 2026 Quarterly report (10-Q) View Quarterly report (10-Q) filed 28 Jul 2026 on sec.gov (opens in a new tab)Filing index for 0001193125-26-321077 (opens in a new tab)
8-K Current report (8-K)
  • Results of operations and financial condition (Item 2.02)
  • Regulation FD disclosure (Item 7.01)
  • Other events (Item 8.01)
  • Financial statements and exhibits (Item 9.01)
View Current report (8-K) filed 24 Jul 2026 on sec.gov (opens in a new tab)Filing index for 0001193125-26-315151 (opens in a new tab)
8-K Current report (8-K)
  • Results of operations and financial condition (Item 2.02)
  • Regulation FD disclosure (Item 7.01)
  • Financial statements and exhibits (Item 9.01)
View Current report (8-K) filed 14 Jul 2026 on sec.gov (opens in a new tab)Filing index for 0001193125-26-302539 (opens in a new tab)
8-KEvent 15 Jun 2026 Current report (8-K)
  • Departure or appointment of directors or officers (Item 5.02)
View Current report (8-K) filed 18 Jun 2026 on sec.gov (opens in a new tab)Filing index for 0001193125-26-275086 (opens in a new tab)
4Event 7 May 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 11 May 2026 on sec.gov (opens in a new tab)Filing index for 0001193125-26-217167 (opens in a new tab)
4Event 28 Apr 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 30 Apr 2026 on sec.gov (opens in a new tab)Filing index for 0001140361-26-018355 (opens in a new tab)

Source: SEC EDGAR. Each row links to the filing on sec.gov.

Related news

No recent headlines mention this company.

Last 90 days of Form 4 filings, from 3 Aug 2026 (US Eastern dates).

Buys code P
None in this period
Sells code S
None in this period
Other all other codes
1 transaction: grants, exercises, tax withholding, gifts and similar

Last transaction:

Insider filings are public records and are not a recommendation. Source: SEC EDGAR.

Sources

Nothing on this page is investment advice.